
Play a role in accelerating the biggest revolution in the history of medicine.
A new Longevity Biotech Fellowship (LBF) is seeking people to come together to build, join or invest in revolutionary longevity biotechnology projects.
Longevity.Technology: The longevity biotech industry has seen incredible growth over the past five years, but it still represents less than 1% of total biotech market capitalisation – and only 0.5% of NIH grants go towards aging biology. This is despite the fact that aging is the root cause of myriad diseases, is responsible for the large majority of physical suffering and is an enormous and expensive burden on healthcare infrastructure. Oh, and it causes death as well.
Aging is a universal problem that affects everyone; this means that the market consists of everyone, and with recent longevity heavyweights agreeing that aging might not be inevitable, but malleable and able to be influenced, there has never been a better time to get involved and make a difference.
And there is light at the end of a tunnel that once seemed markedly more gloomy. Longevity biotech is accelerating, with a seven times increase in private funding in the last seven years; keeping the pedal to the metal and speeding the growth of this industry, Nathan Cheng (program director for ODLB), Mark Hamalainen and Jun Axup (founders of LessDeath and Longevity Summer Camp) have joined forces to launch a new non-profit community.

The Longevity Biotech Fellowship’s mission is to help talented and mission-driven individuals get involved in longevity and maximise their impact, working with other like-minded people – it’s time to break bottlenecks.
Taking a sensible approach, the new Fellowship is casting its net wide, seeking talent in science, engineering, software, data, operations, automation, finance and more. For the founders, it’s not about having a PhD in aging biology, but rather having the mindset to make a contribution, with the Fellowship helping to plug any knowledge gaps, foster connections and make progress.
Over two dozen industry leading founders, investors, scientists, engineers and operators are volunteering their time as mentors for the Fellowship, including Joe Betts-LaCroix of Retro, Kristen Fortney of BioAge, Omri Amirav-Drory of Renewal Bio among others.
New members will receive an intensive orientation in-person retreat, 12-week online core curriculum and a year of access to the community platform with weekly new online content, thriving online discussions, IRL meetups, job and startup fairs and more.
The team behind the new Fellowship has a track record of helping people find jobs, make hires, meet co-founders, get funding and make investments in longevity. But best of all, successful applicants will be joining a community of like-minded professionals working together to maximise healthy human lifespan.

Co-founder Nathan Cheng told Longevity.Technology: “The Longevity Biotech Fellowship will serve as a lighthouse to guide talented individuals towards maximizing their impact on longevity. With the help of our mentors and industry experts, we will orient, connect, and help our members navigate their longevity biotech career journeys – whether that’s finding a co-founder, a new role at a longevity startup, connecting with investors or new collaborators.”
The deadline for applications for the first cohort of the Longevity Biotech Fellowship is 31st December, with the in-person retreat kicking off the cohort on 12th-16th January in Stinson Beach, California — located just one hour away from San Francisco.
Admissions are on a rolling basis and spots are limited. Candidates are highly encouraged to apply early at www.longbiofellowship.org!